AstraZeneca’s Enhertu cancer drug added to China health insurance scheme
The Chinese government said it would add AstraZeneca’s blockbuster breast cancer drug Enhertu to its state-run health insurance scheme from the start of next year. Inclusion in the national reimbursement list makes the drug more widely available to the …